Sukhatme VP - Search Results

1

Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.

Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, Rajakumar A, Daftary A, Shakir AS, Seely EW, Roberts JM, Sukhatme VP, Karumanchi SA, Thadhani R. Wolf M, et al. Among authors: sukhatme vp. J Clin Endocrinol Metab. 2004 Dec;89(12):6239-43. doi: 10.1210/jc.2004-0548. J Clin Endocrinol Metab. 2004. PMID: 15579783

2

First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA. Thadhani R, et al. Among authors: sukhatme vp. J Clin Endocrinol Metab. 2004 Feb;89(2):770-5. doi: 10.1210/jc.2003-031244. J Clin Endocrinol Metab. 2004. PMID: 14764795

3

Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.

Thadhani R, Ecker JL, Mutter WP, Wolf M, Smirnakis KV, Sukhatme VP, Levine RJ, Karumanchi SA. Thadhani R, et al. Among authors: sukhatme vp. Hypertension. 2004 May;43(5):988-92. doi: 10.1161/01.HYP.0000124460.67539.1d. Epub 2004 Mar 15. Hypertension. 2004. PMID: 15023932

4

Preeclampsia: a renal perspective.

Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Karumanchi SA, et al. Among authors: sukhatme vp. Kidney Int. 2005 Jun;67(6):2101-13. doi: 10.1111/j.1523-1755.2005.00316.x. Kidney Int. 2005. PMID: 15882253 Free article. Review.

5

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Maynard SE, et al. Among authors: sukhatme vp. J Clin Invest. 2003 Mar;111(5):649-58. doi: 10.1172/JCI17189. J Clin Invest. 2003. PMID: 12618519 Free PMC article.

6

Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights.

Bdolah Y, Sukhatme VP, Karumanchi SA. Bdolah Y, et al. Among authors: sukhatme vp. Semin Nephrol. 2004 Nov;24(6):548-56. doi: 10.1016/s0270-9295(04)00125-1. Semin Nephrol. 2004. PMID: 15529289 Review.

7

Circulating angiogenic factors and the risk of preeclampsia.

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Levine RJ, et al. Among authors: sukhatme vp. N Engl J Med. 2004 Feb 12;350(7):672-83. doi: 10.1056/NEJMoa031884. Epub 2004 Feb 5. N Engl J Med. 2004. PMID: 14764923 Free article.

8

Urinary placental growth factor and risk of preeclampsia.

Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Levine RJ, et al. Among authors: sukhatme vp. JAMA. 2005 Jan 5;293(1):77-85. doi: 10.1001/jama.293.1.77. JAMA. 2005. PMID: 15632339

9

Soluble endoglin contributes to the pathogenesis of preeclampsia.

Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Venkatesha S, et al. Among authors: sukhatme vp. Nat Med. 2006 Jun;12(6):642-9. doi: 10.1038/nm1429. Epub 2006 Jun 4. Nat Med. 2006. PMID: 16751767

10

Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells.

Venkatesha S, Hanai J, Seth P, Karumanchi SA, Sukhatme VP. Venkatesha S, et al. Among authors: sukhatme vp. Mol Cancer Res. 2006 Nov;4(11):821-9. doi: 10.1158/1541-7786.MCR-06-0110. Mol Cancer Res. 2006. PMID: 17114340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page